For biotech entrepreneur Greg Verdine, opportunity just kept knocking
Read More
Archive for Fog In The News
Introducing Fierce Biotech’s 2023 Fierce 15
Read More
Nature Reviews Drug Discovery: The case for cell-penetrating peptides
Read More
Endpoints: Escaping an improbable upbringing, Greg Verdine places his biggest career bets in drugging the ‘undruggable’
Read More
Insider: A former Harvard chemist just raised $178 million for a biotech startup that plans to treat previously untreatable cancers
Read More
PharmaVOICE 100: WeiQing Zhou
Read More
FierceBiotech: Biopharma begins to hand AI the keys to the research car
Read More
Endpoints: Harvard’s Gregory Verdine has big ambitions for his miniprotein ‘braces’ — and now $107M to guide them to the clinic
Read More
Cambridge Discovery Park Building 400-500 Will be New Headquarters for FogPharma and LifeMine Therapeutics
Read More
FierceBiotech: FogPharma collects $66M to advance cell-penetrating cancer inhibitor
Read More